US 9273136
Fully human anti-human NKG2D monoclonal antibodies
granted A61KA61K2039/505A61P
Quick answer
US patent 9273136 (Fully human anti-human NKG2D monoclonal antibodies) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/505, A61P, A61P29/00, A61P31/00